...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Primary renal cell carcinoma in a transplanted kidney: genetic evidence of recipient origin.
【24h】

Primary renal cell carcinoma in a transplanted kidney: genetic evidence of recipient origin.

机译:移植肾中的原发性肾细胞癌:受体来源的遗传证据。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Primary renal cell carcinoma (RCC) is the most frequent kidney cancer. In renal transplant patients, RCC more commonly arise in the native kidneys, whereas allograft involvement has been just occasionally reported. In these latter cases, a graft origin of tumor cells should be considered and other recipients from the same donor should be investigated. So far, genetic studies to trace the origin of cancer cells have always confirmed the donor origin of these tumors. METHODS: A 58-year-old man developed an RCC in the grafted kidney 14 years after transplantation. Histologic and immunohistochemical studies diagnosed a clear cell RCC with sarcomatoid changes. A nine microsatellite DNA assay was used to compare renal tumor cells with donor's (graft parenchyma) and recipient's (lymph nodes and blood) cells. RESULTS: Of the nine microsatellites analyzed, four turned out to be noninformative and the other five (D1S2734, D1S214, D1S199, D19S219, and Humara) showed different band profiles in donor's and recipient's cells DNA. Tumor and blood profile matching confirmed the recipient origin of neoplastic cells. CONCLUSIONS: We report the first case of a grafted-kidney RCC whose recipient's cell origin has been proved by microsatellite analysis. An origin from the recipient's kidney or bone marrow stem cells is proposed as the more plausible hypothesis.
机译:背景:原发性肾细胞癌(RCC)是最常见的肾癌。在肾移植患者中,RCC更常出现在天然肾脏中,而同种异体移植受累的报道也很少。在后一种情况下,应考虑肿瘤细胞的移植来源,并应调查同一供体的其他受体。迄今为止,追踪癌细胞起源的遗传研究始终证实了这些肿瘤的供体起源。方法:一名58岁的男人在移植后14年在移植肾中形成了RCC。组织学和免疫组化研究诊断为具有肉瘤样变化的透明细胞RCC。使用九种微卫星DNA分析法将肾肿瘤细胞与供体(移植实质)和受体(淋巴结和血液)细胞进行比较。结果:在分析的9个微卫星中,有4个没有信息,而其他5个(D1S2734,D1S214,D1S199,D19S219和Humara)在供体和受体细胞DNA中显示出不同的条带分布。肿瘤和血液轮廓匹配证实了肿瘤细胞的受体来源。结论:我们报道了第一例移植肾肾癌,其接受者的细胞起源已通过微卫星分析得到证实。提出来自受体的肾脏或骨髓干细胞的起源是更合理的假设。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号